Cases & Deals

Bryan, Garnier & Co Limited and ODDO BHF SCA complete €29.8 million capital increase of MedinCell S.A.

Clients Bryan, Garnier & Co Limited (acting via Bryan Garnier Securities SAS) and ODDO BHF SCA

Jones Day represented Bryan, Garnier & Co Limited (acting via Bryan Garnier Securities SAS) and ODDO BHF SCA, as joint global coordinators and joint bookrunners, in connection with the €29.8 million capital increase of MedinCell S.A., a clinical stage pharmaceutical company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.